Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Neurosurgery. 2011 Mar;68(3):705–713. doi: 10.1227/NEU.0b013e31820773b2

Table 3.

Trends in 30 day mortality following neurosurgical treatment of metastatic breast cancer.

30 day mortality Surgery prior to 1996 Surgery after 1996 P value
All surgeries 9.0% (58/585) 10.1% (30/268) 8.1% (28/317) .4
Cranial 9.1% (24/240) 11.2% (12/95) 7.6% (12/145) .3
Laminectomy (no fusion) 9.8% (17/157) <10%* <10%* 1.0
Fusion 8.3% (17/188) <9%* <8%* .8
*

Actual value not reportable due to SEER-Medicare patient confidentiality restrictions on reporting results with N<11